F.-J. Schmitz

Epidemiology and Susceptibility of 3,051<i>Staphylococcus aureus</i>Isolates from 25 University Hospitals Participating in the European SENTRY Study

Ad C. Fluit, C. L. C. Wielders, J. Verhoef et al. · Journal of Clinical Microbiology · 2001 · 287 citations · Full text

Class I integrons in Gram-negative isolates from different European hospitals and association with decreased susceptibility to multiple antibiotic compounds

Pedro Martinez-Freijo, Ad C. Fluit, F.-J. Schmitz et al. · Journal of Antimicrobial Chemotherapy · 1998 · 247 citations · Full text

Integron-negative Isolates, Integron Carriage, Antibiotic Resistance +17

Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals

F.-J. Schmitz, R. Sadurski, Angela Kray et al. · Journal of Antimicrobial Chemotherapy · 2000 · 191 citations · Full text

The effect of reserpine, an inhibitor of multidrug efflux pumps, on the in-vitro activities of ciprofloxacin, sparfloxacin and moxifloxacin against clinical isolates of Staphylococcus aureus

F.-J. Schmitz, Ad C. Fluit, Marc Lückefahr et al. · Journal of Antimicrobial Chemotherapy · 1998 · 159 citations · Full text

Staphylococcus Aureus, In-vitro Activities, Pharmacotherapy +17

Activities of the Glycylcycline Tigecycline (GAR-936) against 1,924 Recent European Clinical Bacterial Isolates

D. Milatović, F.-J. Schmitz, J. Verhoef et al. · Antimicrobial Agents and Chemotherapy · 2002 · 152 citations · Full text